Inventor
SAMARSKY DMITRY
US28 patents
⚠️ This page may combine multiple inventors who share the name “SAMARSKY DMITRY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PHIO PHARM CORP
9 patentsUS10913948B2Feb 9, 2021
RNA interference in dermal and fibrotic indications
PHIO PHARM CORP21 citations94
US10774330B2Sep 15, 2020
Reduced size self-delivering RNAI compounds
PHIO PHARM CORP15 citations94
US10662430B2May 26, 2020
RNA interference in ocular indications
PHIO PHARM CORP14 citations94
US10240149B2Mar 26, 2019
Reduced size self-delivering RNAi compounds
PHIO PHARM CORP23 citations94
US10876119B2Dec 29, 2020
Reduced size self-delivering RNAI compounds
PHIO PHARM CORP7 citations92
US10815485B2Oct 27, 2020
RNA interference in skin indications
PHIO PHARM CORP8 citations92
US11396654B2Jul 26, 2022
Neutral nanotransporters
PHIO PHARM CORP4 citations84
US11118178B2Sep 14, 2021
Reduced size self-delivering RNAI compounds
PHIO PHARM CORP8 citations84
US11584933B2Feb 21, 2023
RNA interference in ocular indications
PHIO PHARM CORP2 citations73
KHVOROVA ANASTASIA
6 patentsUS8796443B2Aug 5, 2014
Reduced size self-delivering RNAi compounds
KHVOROVA ANASTASIA105 citations99
US8664189B2Mar 4, 2014
RNA interference in skin indications
KHVOROVA ANASTASIA60 citations99
US10041073B2Aug 7, 2018
Reduced size self-delivering RNAi compounds
KHVOROVA ANASTASIA24 citations98
US9080171B2Jul 14, 2015
Reduced size self-delivering RNAi compounds
KHVOROVA ANASTASIA91 citations98
US10138485B2Nov 27, 2018
Neutral nanotransporters
KHVOROVA ANASTASIA22 citations97
US9340786B2May 17, 2016
RNA interference in dermal and fibrotic indications
KHVOROVA ANASTASIA49 citations97
RXI PHARMACEUTICALS CORP
5 patentsUS9175289B2Nov 3, 2015
Reduced size self-delivering RNAi compounds
RXI PHARMACEUTICALS CORP80 citations98
US9938530B2Apr 10, 2018
RNA interference in skin indications
RXI PHARMACEUTICALS CORP25 citations97
US9303259B2Apr 5, 2016
RNA interference in skin indications
RXI PHARMACEUTICALS CORP46 citations97
US10184124B2Jan 22, 2019
RNA interference in ocular indications
RXI PHARMACEUTICALS CORP23 citations93
US9963702B2May 8, 2018
RNA interference in dermal and fibrotic indications
RXI PHARMACEUTICALS CORP23 citations93
SILENCE THERAPEUTICS GMBH
5 patentsUS11015198B2May 25, 2021
Products and compositions
SILENCE THERAPEUTICS GMBH14 citations84
US11414660B2Aug 16, 2022
Products and compositions
SILENCE THERAPEUTICS GMBH2 citations69
US11299738B2Apr 12, 2022
Further novel oligonucleotide-ligand conjugates
SILENCE THERAPEUTICS GMBH0 citations62
US12084656B2Sep 10, 2024
Products and compositions
SILENCE THERAPEUTICS GMBH1 citations61
US11987794B2May 21, 2024
Products and compositions
SILENCE THERAPEUTICS GMBH0 citations59